BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24964524)

  • 1. [Testosterone: a treatment for the prevention of cardiovascular disease].
    Gencer B; Köhler Ballan B; Philippe J; Mach F
    Rev Med Suisse; 2014 May; 10(432):1173-8. PubMed ID: 24964524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
    Hassan J; Barkin J
    Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
    Seisen T; Rouprêt M; Gallais JL; Costa P
    Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of Testosterone Therapy.
    Lee OD; Tillman K
    Am J Mens Health; 2016 Jan; 10(1):68-72. PubMed ID: 25398416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.
    Sigalos JT; Pastuszak AW; Khera M
    Med Clin North Am; 2018 Mar; 102(2):361-372. PubMed ID: 29406064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
    Maganty A; Osterberg EC; Ramasamy R
    Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Testosterone deficit syndrome in the old male].
    Chantada Abal V; Vázquez-Martul Pazos D; Portela Pereira P; Aller Rodriguez M; Barreiro Mallo A; Sánchez Vázquez A
    Arch Esp Urol; 2013 Sep; 66(7):684-8. PubMed ID: 24047627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events.
    Corona G; Rastrelli G; Maseroli E; Fralassi N; Sforza A; Forti G; Mannucci E; Maggi M
    Andrology; 2014 Sep; 2(5):741-7. PubMed ID: 25044637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypogonadism management and cardiovascular health.
    Auerbach JM; Khera M
    Postgrad Med; 2020 Dec; 132(sup4):35-41. PubMed ID: 32799602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular issues in hypogonadism and testosterone therapy.
    Shabsigh R; Katz M; Yan G; Makhsida N
    Am J Cardiol; 2005 Dec; 96(12B):67M-72M. PubMed ID: 16387571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Health, Erectile Dysfunction, and Testosterone Replacement: Controversies and Correlations.
    Elkhoury FF; Rambhatla A; Mills JN; Rajfer J
    Urology; 2017 Dec; 110():1-8. PubMed ID: 28774772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy and cardiovascular events.
    Çatakoğlu AB; Kendirci M
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Testosterone supplementary therapy for type-2 diabetes mellitus males with hypogonadism: Controversy and analysis].
    Cheng Z; Zhang LY; Chen GM; He W; Cai K; Liao ZH
    Zhonghua Nan Ke Xue; 2017 Aug; 23(8):739-744. PubMed ID: 29726651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone and the aging male: to treat or not to treat?
    Bain J
    Maturitas; 2010 May; 66(1):16-22. PubMed ID: 20153946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.